Moleculon drug delivery system
Firm said it expects to begin clinical testing of a system that permits two drugs to be delivered simultaneously, each at its own controlled rate of delivery, in 1985. The system utilizes Moleculon's poroplastic membrane which is applied under an adhesive patch. Gentamicin and clindamycin will be used in the initial delivery system
You may also be interested in...
The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant step on the road to addressing gender inequality at the very top level of management in the world of big pharma.
The FDA has published fresh guidance taking a tougher stance on sponsor reasons for needing more time to respond to complete response letters.
Stada has named Yann Brun to become the group’s new head of global development, portfolio, regulatory and business development, replacing Robert Knerr. The move is the latest in a string of key appointments at Stada as the firm builds on a series of acquisitions and deals.